By Steve WagnerFollowing up on its aggressive showing last year, Swissray International unveiled several products during the 2000 RSNA show last month, including the ddRModulaire and the work-in-progress ddRFluoroscopy system. In all, five products were
By Steve Wagner
Following up on its aggressive showing last year, Swissray International unveiled several products during the 2000 RSNA show last month, including the ddRModulaire and the work-in-progress ddRFluoroscopy system. In all, five products were introduced.
Last year, Swissray introduced its ddRCombi and ddRChest systems. Those followed the introduction of the company's flagship ddRMulti system in the mid-1990s.
Designed for affordability, the ddRModulaire was revealed during a news conference. Its compact design features an overlapping quad-charge-coupled device detector and a free-swinging isocentric arm that facilitates fast positioning.
"This will do for direct digital radiography what cellular has done for communications," said John Monahan, national accounts manager for Swissray America. "In most cases, the investment in this system will be returned in less than two years."
The ddRModulaire is essentially an entry-level system for buyers who have limited space and capital. The system's cost is comparable to retrofits offered by competing firms, Swissray said.
Unlike the ddrModulaire, ddRFluoroscopy is a work-in-progress, with full-motion imaging designed to complement high-resolution radiographic images. The system is being touted as the first completely digital, direct digital radiography fluoroscopy unit, providing users with digital acquisition, processing, output, and display, said Dr. Leonard Berliner, medical director for Swissray International.
Also unveiled were:
Swissray also announced that DIANAssociates, a telemedicine service provider based in Maryland, has ordered 10 direct digital
radiography systems for tuberculosis screening at 10 U.S. sites. n
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.